文献速递神经肿瘤

数字聚合酶链反应定量检测SERPINA1可预测高级别胶质瘤预后

Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma.
PubMed 文献 · World Neurosurg · 2018-01-05

本研究用数字聚合酶链反应(PCR)定量检测29例高级别胶质瘤(HGG)石蜡包埋手术标本中SERPINA1的表达,其中世界卫生组织(WHO)III级7例、IV级22例,并分析其与预后的关系。结果显示SERPINA1在III级和IV级HGG组织中的表达率分别为14.3%和63.6%(P=0.035),低表达组中位总生存期38.8个月长于高表达组的15.3个月(P=0.030)。结论认为SERPINA1在IV级HGG中的表达频率和表达量高于III级,高表达提示HGG预后不良。

要点

  • 数字PCR检测显示SERPINA1在WHO IV级HGG组织中的表达率为63.6%,高于III级的14.3%(P=0.035)。
  • SERPINA1低表达组中位总生存期38.8个月,长于高表达组的15.3个月(P=0.030)。
  • SERPINA1高表达提示高级别胶质瘤预后不良。

核心结论

  • SERPINA1在IV级HGG中的表达频率和表达量高于III级HGG,且SERPINA1高表达提示HGG预后不良。

研究设计与样本

  • 研究纳入29例HGG患者的福尔马林固定石蜡包埋(FFPE)手术标本,其中WHO III级7例、WHO IV级22例,并采用人胶质母细胞瘤细胞系U87和U118进行分析。
  • 采用免疫染色进行定性评估、数字PCR进行定量评估,以检测SERPINA1的表达。

主要发现

  • 免疫染色显示SERPINA1在胶质瘤组织和胶质母细胞瘤多形性细胞系中均有表达。
  • 数字PCR分析显示SERPINA1在III级HGG组织中的表达率为14.3%,在IV级HGG组织中的表达率为63.6%(P=0.035)。
  • SERPINA1低表达组的中位总生存期为38.8个月,长于高表达组的15.3个月(P=0.030)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: SERPINA1 plays an anti-inflammatory role in protecting tissues from proteolytic mechanisms. SERPINA1 is positive in gliomas by immunohistochemical analysis; however, the role of SERPINA1, including the relationship with prognosis, has been uncertain. In recent years, digital polymerase chain reaction (PCR) has provided ultra-sensitive assessment of messenger RNA expression from formalin-fixed paraffin-embedded (FFPE) tissues. OBJECTIVE: In this study, we quantitatively determined the expression of SERPINA1 in high-grade gliomas (HGGs) using digital PCR, and we analyzed its relationship with prognosis. METHODS: Twenty-nine FFPE surgical samples from patients with HGGs (7 of World Health Organization [WHO] grade III and 22 of WHO grade IV), and human glioblastoma cell lines, U87 and U118, were used for analysis. A qualitative assessment using immunostaining and quantitative assessment using digital PCR were performed to assess the expression of SERPINA1. RESULTS: The expression of SERPINA1 was demonstrated in glioma tissues and glioblastoma multiforme cell lines by immunostaining. Digital PCR analysis showed that SERPINA1 was expressed in 14.3% and 63.6% of the tissues from patients with grade III and grade IV HGG, respectively (P = 0.035). The median overall survival of 38.8 months in the low SERPINA1 expression group was longer than that of 15.3 months in the high expression group (P = 0.030). CONCLUSIONS: The frequency and the amount of SERPINA1 expression were higher in grade IV than in grade III HGGs. The high expression of SERPINA1 indicates a poor prognosis of HGGs.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ookawa S, Wanibuchi M, Kataoka-Sasaki Y, et al. Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma. World Neurosurg. 2018. PMID: 29309973. doi:10.1016/j.wneu.2017.12.166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。